$51.39 -0.92 (%) Mylan N.V. - NASDAQ

Feb. 5, 2016 | 04:00 PM

Partner Headlines

  1. David Einhorn Comments on Mylan

    GuruFocus | Jan. 19, 2016 | 17:32PM EST
  2. Mylan, Momenta Team Up To Develop Biosimilar Drugs

    IBD | Jan. 8, 2016 | 15:34PM EST
  3. Clinton To Target 'Inversions' With Exit Tax

    FoxBusiness | Dec. 9, 2015 | 14:41PM EST
  4. Pfizer-Allergan Won't Be the Last Inversion

    FoxBusiness | Nov. 23, 2015 | 12:26PM EST
  5. Glenview's Larry Robbins Lowers Drug Manufacturers, Raises Health Care Providers

    GuruFocus | Nov. 20, 2015 | 18:26PM EST
  6. Health Care Investor Larry Robbins Sells Drug Manufacturers, Buys Providers

    GuruFocus | Nov. 20, 2015 | 18:26PM EST
  7. Pfizer-Allergan A Go Despite New Tax Inversion Rules?

    IBD | Nov. 19, 2015 | 19:05PM EST
  8. Pfizer, Allergan Near Deal As Tax Inversion Rules Loom

    IBD | Nov. 18, 2015 | 22:38PM EST
  9. Treasury Plans New 'Targeted' Tax-Inversion Crackdown

    IBD | Nov. 18, 2015 | 18:05PM EST
  10. John Paulson Keeps Gold, Buys Drug Manufacturers in Q3

    GuruFocus | Nov. 17, 2015 | 13:13PM EST
  11. Benzinga's Weekend M&A Chatter

    Benzinga | Nov. 15, 2015 | 20:01PM EST
  12. Vanguard Raises Stakes in Biogen, Mylan, Merck

    GuruFocus | Nov. 15, 2015 | 13:10PM EST
  13. Mylan Finally Over Perrigo?

    IBD | Nov. 13, 2015 | 18:59PM EST
  14. Worst Performing Industries For November 13, 2015

    Benzinga | Nov. 13, 2015 | 12:28PM EST
  15. Major Averages Take More Heat; Retail Stocks Slammed On Weak Data

    IBD | Nov. 13, 2015 | 11:44AM EST
  16. Stocks Falter At Start Of Trade; Fossil, El Pollo, GameStop Slide

    IBD | Nov. 13, 2015 | 10:34AM EST
  17. Benzinga's Volume Movers

    Benzinga | Nov. 13, 2015 | 10:23AM EST
  18. Mylan Bid For Perrigo Fails On Shareholder Vote

    IBD | Nov. 13, 2015 | 09:58AM EST
  19. Stock Futures Dig Deeper; Perrigo, Nordstrom, Cisco Tumble

    IBD | Nov. 13, 2015 | 09:05AM EST
  20. Mylan To Lose Hostile Takeover Of Perrigo

    Benzinga | Nov. 13, 2015 | 09:03AM EST
  21. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 13, 2015 | 08:20AM EST
  22. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 13, 2015 | 08:14AM EST
  23. Mylan, Perrigo bicker over bid

    IBD | Nov. 12, 2015 | 18:45PM EST
  24. Mylan, Perrigo Face Off As Takeover Vote Nears

    IBD | Nov. 12, 2015 | 12:18PM EST
  25. Perrigo Sends Letter to Holders, Discusses Mylan Deal; Says 'Corporate Governance, Mylan Style: A Question Of Trust

    Benzinga | Nov. 9, 2015 | 07:05AM EST
  26. Keeley Funds Comments on Mylan NV

    GuruFocus | Nov. 3, 2015 | 13:58PM EST
  27. Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer

    GuruFocus | Nov. 2, 2015 | 12:33PM EST
  28. AbbVie, Mylan Profit Surprise

    IBD | Oct. 30, 2015 | 18:13PM EST
  29. Perrigo Continues to Oppose Mylan's Inadequate Offer

    Benzinga | Oct. 30, 2015 | 15:39PM EST
  30. Stocks Dip In Light Trade; LinkedIn Soars After Hours

    IBD | Oct. 29, 2015 | 17:18PM EST
  31. Tel Aviv District Court Rules in Favor of Mylan Listing on Tel Aviv Stock Exchange

    Benzinga | Oct. 28, 2015 | 15:15PM EST
  32. Gilead, Biotechs Were TPP Losers; Boeing Is Upbeat

    IBD | Oct. 6, 2015 | 13:37PM EST
  33. Valeant Defended After Politics-Induced Sell-Off

    IBD | Sep. 29, 2015 | 12:45PM EST
  34. Benzinga's Weekend M&A Chatter

    Benzinga | Sep. 27, 2015 | 18:53PM EST
  35. Benzinga's M&A Chatter for Thursday September 17, 2015

    Benzinga | Sep. 17, 2015 | 19:11PM EST
  36. Theravance Biopharma and Mylan Initiate Phase 3 Program for Revefenacin (TD-4208) for Treatment ...

    GuruFocus | Sep. 15, 2015 | 00:02AM EST
  37. Theravance Biopharma, Mylan Report Initiation of Phase 3 Program for Revefenacin for the Treatment of COPD

    Benzinga | Sep. 14, 2015 | 08:06AM EST
  38. Alan Fournier Sells Nine Stakes in Second Quarter

    GuruFocus | Sep. 12, 2015 | 22:49PM EST
  39. Benzinga's M&A Chatter for Tuesday September 8, 2015

    Benzinga | Sep. 8, 2015 | 21:02PM EST
  40. Benzinga's Weekend M&A Chatter

    Benzinga | Aug. 30, 2015 | 20:30PM EST
  41. Sequoia Fund Comments on Perrigo

    GuruFocus | Aug. 28, 2015 | 15:27PM EST
  42. Mylan Confirms USPTO Institutes Inter Partes Review Proceedings vs Two Copaxone 40 mg/mL Dosing Patents

    Benzinga | Aug. 25, 2015 | 15:05PM EST
  43. Kyle Bass Focuses on Fuel, Pharmaceutical Stocks in Second Quarter

    GuruFocus | Aug. 24, 2015 | 19:15PM EST
  44. Taconic Capital Buys Time Warner Cable, Broadcom

    GuruFocus | Aug. 23, 2015 | 05:58AM EST
  45. David Tepper Buys 3 Substantial New Holdings in Second Quarter

    GuruFocus | Aug. 14, 2015 | 18:27PM EST
  46. David Tepper Buys Apple, Alibaba and Mylan in Second Quarter

    GuruFocus | Aug. 14, 2015 | 18:27PM EST
  47. ISS Affirms Perrigo's Position That Proposed Mylan Transaction Would Be Value Destructive

    Benzinga | Aug. 14, 2015 | 11:08AM EST
  48. Mylan Responds to ISS Recommendation Regarding Perrigo Transaction, Confident Acquiring Perrigo Is Right Next Strategic Step

    Benzinga | Aug. 14, 2015 | 09:21AM EST
  49. Benzinga's M&A Chatter for Thursday August 13, 2015

    Benzinga | Aug. 13, 2015 | 19:01PM EST
  50. Top Performing Industries For August 13, 2015

    Benzinga | Aug. 13, 2015 | 10:46AM EST
Trading Center